La ricerca del lupus anticoagulant: raccomandazioni del gruppo di studio sulla coagulazione di SIPMeL

Translated title of the contribution: Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL)—guidelines for laboratory detection of Lupus Anticoagulant (LA)

Cristina Legnani, Giuliana Martini, Michele Bertini, Pierfrancesco Agostini, Francesco Bondanini, Maria Rita Cozzi, Marta Sofia Angela Demicheli, Giovina Di Felice, Cristina Novembrino, Oriana Paoletti, Simona Pedrini, Lucia Ruocco, Agostino Steffan, Lucia Terzuoli, Sophie Testa

Research output: Contribution to journalArticle

Abstract

To diagnose antiphospholipid syndrome (APS) it is necessary the presence of at least one clinical criterion (venous/arterial thrombosis or pregnancy complications) and persistent positivity of antiphospholipid antibodies (confirmed at least 12 weeks apart). The laboratory criteria to define the presence of antiphospholipid antibodies are: LA presence and/or increase of anticardiolipin and/or anti ß2 Glycoprotein I antibodies (IgG or IgM). Several variables can influence the result of the tests used for LA diagnosis, standardization of tests is poor and a wide inter-laboratory variability has been reported in terms of sensitivity and specificity. The probability of diagnostic errors (false negativity or false positivity) is therefore quite high. In order to improve the diagnostic accuracy of LA tests in 2009 the specific subcommittee for standardization of the methods of the International Society on Thrombosis and Haemostasis (ISTH) has updated the guidelines previously published. The Study Group on Coagulation of the Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL) summarizes in this article the ISTH guidelines. Subsequently, the Clinical & Laboratory Standard Institute (CLSI) has published its guideline which shows, in some respects, different or conflicting positions. Since the recommendations indicated by the CLSI are followed by many Laboratories, we tried to critically review these different positions. The Study Group of SIPMeL deems necessary to reiterate that for APS diagnosis the LA tests must be performed according to the ISTH guidelines.

Original languageItalian
Pages (from-to)156-164
Number of pages9
JournalRivista Italiana della Medicina di Laboratorio
Volume14
Issue number3
DOIs
Publication statusPublished - Sep 7 2018

Fingerprint

Lupus Coagulation Inhibitor
Clinical Pathology
Pathology
Medicine
Guidelines
Hemostasis
Antiphospholipid Antibodies
Thrombosis
Antiphospholipid Syndrome
Standardization
Pregnancy Complications
Coagulation
Diagnostic Errors
Venous Thrombosis
Immunoglobulin M
Glycoproteins
Immunoglobulin G
Sensitivity and Specificity
Antibodies

ASJC Scopus subject areas

  • Medical Laboratory Technology
  • Biochemistry, medical

Cite this

La ricerca del lupus anticoagulant : raccomandazioni del gruppo di studio sulla coagulazione di SIPMeL. / Legnani, Cristina; Martini, Giuliana; Bertini, Michele; Agostini, Pierfrancesco; Bondanini, Francesco; Cozzi, Maria Rita; Demicheli, Marta Sofia Angela; Di Felice, Giovina; Novembrino, Cristina; Paoletti, Oriana; Pedrini, Simona; Ruocco, Lucia; Steffan, Agostino; Terzuoli, Lucia; Testa, Sophie.

In: Rivista Italiana della Medicina di Laboratorio, Vol. 14, No. 3, 07.09.2018, p. 156-164.

Research output: Contribution to journalArticle

Legnani, C, Martini, G, Bertini, M, Agostini, P, Bondanini, F, Cozzi, MR, Demicheli, MSA, Di Felice, G, Novembrino, C, Paoletti, O, Pedrini, S, Ruocco, L, Steffan, A, Terzuoli, L & Testa, S 2018, 'La ricerca del lupus anticoagulant: raccomandazioni del gruppo di studio sulla coagulazione di SIPMeL', Rivista Italiana della Medicina di Laboratorio, vol. 14, no. 3, pp. 156-164. https://doi.org/10.1007/s13631-018-0185-y
Legnani, Cristina ; Martini, Giuliana ; Bertini, Michele ; Agostini, Pierfrancesco ; Bondanini, Francesco ; Cozzi, Maria Rita ; Demicheli, Marta Sofia Angela ; Di Felice, Giovina ; Novembrino, Cristina ; Paoletti, Oriana ; Pedrini, Simona ; Ruocco, Lucia ; Steffan, Agostino ; Terzuoli, Lucia ; Testa, Sophie. / La ricerca del lupus anticoagulant : raccomandazioni del gruppo di studio sulla coagulazione di SIPMeL. In: Rivista Italiana della Medicina di Laboratorio. 2018 ; Vol. 14, No. 3. pp. 156-164.
@article{bd5f5a460a134f46b9b2d782e4c01cdd,
title = "La ricerca del lupus anticoagulant: raccomandazioni del gruppo di studio sulla coagulazione di SIPMeL",
abstract = "To diagnose antiphospholipid syndrome (APS) it is necessary the presence of at least one clinical criterion (venous/arterial thrombosis or pregnancy complications) and persistent positivity of antiphospholipid antibodies (confirmed at least 12 weeks apart). The laboratory criteria to define the presence of antiphospholipid antibodies are: LA presence and/or increase of anticardiolipin and/or anti {\ss}2 Glycoprotein I antibodies (IgG or IgM). Several variables can influence the result of the tests used for LA diagnosis, standardization of tests is poor and a wide inter-laboratory variability has been reported in terms of sensitivity and specificity. The probability of diagnostic errors (false negativity or false positivity) is therefore quite high. In order to improve the diagnostic accuracy of LA tests in 2009 the specific subcommittee for standardization of the methods of the International Society on Thrombosis and Haemostasis (ISTH) has updated the guidelines previously published. The Study Group on Coagulation of the Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL) summarizes in this article the ISTH guidelines. Subsequently, the Clinical & Laboratory Standard Institute (CLSI) has published its guideline which shows, in some respects, different or conflicting positions. Since the recommendations indicated by the CLSI are followed by many Laboratories, we tried to critically review these different positions. The Study Group of SIPMeL deems necessary to reiterate that for APS diagnosis the LA tests must be performed according to the ISTH guidelines.",
keywords = "Antiphospholipid antibodies, Antiphospholipid syndrome, Guidelines, LA, Lupus Anticoagulant",
author = "Cristina Legnani and Giuliana Martini and Michele Bertini and Pierfrancesco Agostini and Francesco Bondanini and Cozzi, {Maria Rita} and Demicheli, {Marta Sofia Angela} and {Di Felice}, Giovina and Cristina Novembrino and Oriana Paoletti and Simona Pedrini and Lucia Ruocco and Agostino Steffan and Lucia Terzuoli and Sophie Testa",
year = "2018",
month = "9",
day = "7",
doi = "10.1007/s13631-018-0185-y",
language = "Italian",
volume = "14",
pages = "156--164",
journal = "Rivista Italiana della Medicina di Laboratorio",
issn = "1825-859X",
publisher = "SIMeL Societa Italiana di Medicina di Laboratorio",
number = "3",

}

TY - JOUR

T1 - La ricerca del lupus anticoagulant

T2 - raccomandazioni del gruppo di studio sulla coagulazione di SIPMeL

AU - Legnani, Cristina

AU - Martini, Giuliana

AU - Bertini, Michele

AU - Agostini, Pierfrancesco

AU - Bondanini, Francesco

AU - Cozzi, Maria Rita

AU - Demicheli, Marta Sofia Angela

AU - Di Felice, Giovina

AU - Novembrino, Cristina

AU - Paoletti, Oriana

AU - Pedrini, Simona

AU - Ruocco, Lucia

AU - Steffan, Agostino

AU - Terzuoli, Lucia

AU - Testa, Sophie

PY - 2018/9/7

Y1 - 2018/9/7

N2 - To diagnose antiphospholipid syndrome (APS) it is necessary the presence of at least one clinical criterion (venous/arterial thrombosis or pregnancy complications) and persistent positivity of antiphospholipid antibodies (confirmed at least 12 weeks apart). The laboratory criteria to define the presence of antiphospholipid antibodies are: LA presence and/or increase of anticardiolipin and/or anti ß2 Glycoprotein I antibodies (IgG or IgM). Several variables can influence the result of the tests used for LA diagnosis, standardization of tests is poor and a wide inter-laboratory variability has been reported in terms of sensitivity and specificity. The probability of diagnostic errors (false negativity or false positivity) is therefore quite high. In order to improve the diagnostic accuracy of LA tests in 2009 the specific subcommittee for standardization of the methods of the International Society on Thrombosis and Haemostasis (ISTH) has updated the guidelines previously published. The Study Group on Coagulation of the Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL) summarizes in this article the ISTH guidelines. Subsequently, the Clinical & Laboratory Standard Institute (CLSI) has published its guideline which shows, in some respects, different or conflicting positions. Since the recommendations indicated by the CLSI are followed by many Laboratories, we tried to critically review these different positions. The Study Group of SIPMeL deems necessary to reiterate that for APS diagnosis the LA tests must be performed according to the ISTH guidelines.

AB - To diagnose antiphospholipid syndrome (APS) it is necessary the presence of at least one clinical criterion (venous/arterial thrombosis or pregnancy complications) and persistent positivity of antiphospholipid antibodies (confirmed at least 12 weeks apart). The laboratory criteria to define the presence of antiphospholipid antibodies are: LA presence and/or increase of anticardiolipin and/or anti ß2 Glycoprotein I antibodies (IgG or IgM). Several variables can influence the result of the tests used for LA diagnosis, standardization of tests is poor and a wide inter-laboratory variability has been reported in terms of sensitivity and specificity. The probability of diagnostic errors (false negativity or false positivity) is therefore quite high. In order to improve the diagnostic accuracy of LA tests in 2009 the specific subcommittee for standardization of the methods of the International Society on Thrombosis and Haemostasis (ISTH) has updated the guidelines previously published. The Study Group on Coagulation of the Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL) summarizes in this article the ISTH guidelines. Subsequently, the Clinical & Laboratory Standard Institute (CLSI) has published its guideline which shows, in some respects, different or conflicting positions. Since the recommendations indicated by the CLSI are followed by many Laboratories, we tried to critically review these different positions. The Study Group of SIPMeL deems necessary to reiterate that for APS diagnosis the LA tests must be performed according to the ISTH guidelines.

KW - Antiphospholipid antibodies

KW - Antiphospholipid syndrome

KW - Guidelines

KW - LA

KW - Lupus Anticoagulant

UR - http://www.scopus.com/inward/record.url?scp=85052724331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052724331&partnerID=8YFLogxK

U2 - 10.1007/s13631-018-0185-y

DO - 10.1007/s13631-018-0185-y

M3 - Articolo

AN - SCOPUS:85052724331

VL - 14

SP - 156

EP - 164

JO - Rivista Italiana della Medicina di Laboratorio

JF - Rivista Italiana della Medicina di Laboratorio

SN - 1825-859X

IS - 3

ER -